The research library, bottled.

What the research shows

The most direct companion-animal evidence is a pharmacokinetic study in beagle dogs, which mapped how the compound moves through the body. The wider literature is rodent: rat tendon and gut-lining models dominate, with consistent signals around the body's normal recovery processes. Controlled outcome trials in dogs and cats do not exist yet. That gap is why we suggest reading the studies with your veterinarian.

What the research shows

The pairing appears throughout the literature because the two sequences are studied for complementary pathways: gut lining and tissue maintenance on one side, soft-tissue mobility on the other. Each compound has its own preclinical record, mostly rodent and in-vitro. The blend itself has not been studied as a combination in companion animals. We say that plainly so you can weigh it with your veterinarian.

What the research shows

GHK-Cu carries decades of skin research, mostly in cell cultures and rodent models of normal skin barrier and connective-tissue maintenance. Veterinary-specific trials are thin, and coat interest in animals is extrapolated from that base. It is one of the older research threads we follow. Your veterinarian can help you read it for your animal.

What the research shows

Klow is built around KPV, the tripeptide studied in gut-lining and immune-balance models. The supporting literature is preclinical: cell cultures and rodents, with early but consistent signals. No published trials test the blend in companion animals. Bring the research to your veterinarian and decide together.